Katarzyna Tilgner
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Genome-wide screening identifies Polycomb repressive complex 1.3 as an essential regulator of human naïve pluripotent cell reprogramming.
Journal: Science advances
Published: March 25, 2022
Modeling HNF1B-associated monogenic diabetes using human iPSCs reveals an early stage impairment of the pancreatic developmental program.
Journal: Stem cell reports
Published: May 17, 2021
Pluripotent Stem Cell-Derived Hematopoietic Progenitors Are Unable to Downregulate Key Epithelial-Mesenchymal Transition-Associated miRNAs.
Journal: Stem cells (Dayton, Ohio)
Published: May 24, 2017
The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages.
Journal: The Journal of cell biology
Published: January 19, 2016
An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes.
Journal: Stem cells translational medicine
Published: March 05, 2014
Brief report: a human induced pluripotent stem cell model of cernunnos deficiency reveals an important role for XLF in the survival of the primitive hematopoietic progenitors.
Journal: Stem cells (Dayton, Ohio)
Published: November 10, 2012
A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors.
Journal: Cell death and differentiation
Published: October 26, 2012
Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors.
Journal: Stem cells (Dayton, Ohio)
Published: August 02, 2012
Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease.
Journal: Stem cells (Dayton, Ohio)
Published: February 08, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026